1. Home
  2. DTCK vs VIVS Comparison

DTCK vs VIVS Comparison

Compare DTCK & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Davis Commodities Limited

DTCK

Davis Commodities Limited

HOLD

Current Price

$0.29

Market Cap

7.7M

Sector

Industrials

ML Signal

HOLD

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

HOLD

Current Price

$1.90

Market Cap

8.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DTCK
VIVS
Founded
1999
2007
Country
Singapore
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7M
8.1M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
DTCK
VIVS
Price
$0.29
$1.90
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.0M
36.4K
Earning Date
12-23-2025
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$160,529,000.00
$140,000.00
Revenue This Year
N/A
$42.38
Revenue Next Year
N/A
$15.42
P/E Ratio
N/A
N/A
Revenue Growth
0.43
35.92
52 Week Low
$0.23
$1.41
52 Week High
$6.89
$21.96

Technical Indicators

Market Signals
Indicator
DTCK
VIVS
Relative Strength Index (RSI) 41.71 44.41
Support Level $0.30 $1.98
Resistance Level $0.33 $2.18
Average True Range (ATR) 0.03 0.15
MACD 0.02 0.01
Stochastic Oscillator 3.33 14.29

Price Performance

Historical Comparison
DTCK
VIVS

About DTCK Davis Commodities Limited

Davis Commodities Ltd is an agricultural commodity trading company based in Singapore, which specializes in the trading of three main categories of agricultural commodities, namely sugar, rice, and oil and fat products. It distributes agricultural commodities to various markets, including Asia, Africa, and the Middle East. The company also provides customers of commodity offerings with complementary, ancillary services such as warehouse handling and storage, and logistics services. The Company operates across four main segments: the sale of sugar, rice, oil, and fat products, and others. Among these, the sale of sugar stands out as the primary revenue generator, contributing significantly to the company's overall income.

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

Share on Social Networks: